Bold Predictions for Human Genomics by 2030: An NHGRI Seminar Series
NHGRI will host a new seminar series this year on the “Bold Predictions for Human Genomics by 2030” that are described in NHGRI’s “Strategic Vision for Improving Human Health at the Forefront of Genomics.” Beginning in February — and coinciding with the 20th anniversary of the publication that reported the draft human genome sequence — this 10-part seminar series is planned to occur roughly each month throughout 2021.
Related Video: The Future of Genomics: 10 Bold Predictions
About the Sessions
For each session, two speakers will use a specific bold prediction as an aspirational theme to discuss their own research and speculate about next decade of genomic advancements. A moderated question and answer session will follow the speakers. The sessions, which will be held via Zoom for the foreseeable future will be open to the public and video recorded for later viewing on the GenomeTV channel of YouTube.
Session 4 - May 25, 2021, 3 p.m. to 4:30 p.m. ET
Bold Prediction #4: Research in human genomics will have moved beyond population descriptors based on historic social constructs such as race.
Charmaine Royal, Ph.D.
Genevieve Wojcik, Ph.D.
Johns Hopkins University
Vence Bonham, Jr., J.D.
Session 5 - June 7, 2021, 3 p.m. to 4:30 p.m. ET
Bold Prediction #5: Studies involving analyses of genome sequences and associated phenotypic information for millions of human participants will be regularly featured at school science fairs.
Neil Lamb, Ph.D.
HudsonAlpha Institute for Biotechnology
Albert Einstein Distinguished Educator Fellow, Office of Congressman Mark DeSaulnier (CA-11)
Lawrence Brody, Ph.D.
Session 6 - July 12, 2021, 3 p.m. to 4:30 p.m.
Bold Prediction #6: The regular use of genomic information will have transitioned from boutique to mainstream in all clinical settings, making genomic testing as routine as complete blood counts (CBCs).
Jennifer Posey, M.D., Ph.D.
Baylor College of Medicine
Katrina Armstrong, M.D.
Massachusetts General Hospital & Harvard Medical School
Session 7 - September 16, 2021, 3 p.m. to 4:30 p.m.
Bold Prediction #7: The clinical relevance of all encountered genomic variants will be readily predictable, rendering the diagnostic designation “variant of uncertain significance (VUS)” obsolete.
Heidi Rehm, Ph.D.
Broad Institute, Harvard Medical School & Massachusetts General Hospital
Douglas Fowler, Ph.D.
University of Washington
Ben Solomon, M.D.
Session 8 - October 4, 2021, 3 p.m. to 4:30 p.m.
Bold Prediction #8: A person’s complete genome sequence along with informative annotations can be securely and readily accessible on their smartphone.
Gillian Hooker, Ph.D., ScM, LCGC
Sarah Bates, M.S.
Session 9 - November 1, 2021, 3 p.m. to 4:30 p.m.
Bold Prediction #9: Individuals from ancestrally diverse backgrounds will benefit equitably from advances in human genomics.
Robert Winn, M.D.
Virginia Commonwealth University
Alicia Martin, Ph.D.
Massachusetts General Hospital, Harvard Medical School & Broad Institute
Chris Gunter, Ph.D.
Session 10 - January 10, 2022, 3 p.m. to 4:30 p.m.
Bold Prediction #10: Genomic discoveries will lead to curative therapies involving genomic modifications for dozens of genetic diseases.
Timothy Yu, M.D., Ph.D.
Boston Children’s Hospital & Harvard Medical School
Alexis Thompson, M.D., M.P.H.
Ann & Robert H. Lurie Children's Hospital of Chicago & Northwestern University Feinberg School of Medicine
Dan Kastner, M.D., Ph.D.
Session 1 - February 1, 2021, 3 p.m. to 4:30 p.m. ET
Bold Prediction #1: Generating and analyzing a complete human genome sequence will be routine for any research laboratory, becoming as straightforward as carrying out a DNA purification.
Evan Eichler, Ph.D.
University of Washington
Karen Miga, Ph.D.
University of California, Santa Cruz
Eric Green, M.D., Ph.D.
Session 2 - March 8, 2021, 3 p.m. to 4:30 p.m. ET
Bold Prediction #2: The biological function(s) of every human gene will be known; for non-coding elements in the human genome, such knowledge will be the rule rather than the exception.
Nancy Cox, Ph.D.
Neville Sanjana, Ph.D.
NY Genome Center
Carolyn Hutter, Ph.D.
Session 3 - April 12, 2021, 3 p.m. to 4:30 p.m. ET
Bold Prediction #3: The general features of the epigenetic landscape and transcriptional output will be routinely incorporated into predictive models of the impact of genotype on phenotype.
Tom Gingeras, Ph.D.
Cold Spring Harbor Laboratory
Tuuli Lappalainen, Ph.D.
NY Genome Center
Paul Liu, M.D., Ph.D.
Last updated: April 12, 2021